3 results
The primary objective of this study is to demonstrate the efficacy of the combination therapy of aliskiren (150 mg and 300 mg) and HCTZ 25 mg in hypertensive patients who do not show sufficient blood pressure response to a 4-week treatment of HCTZ…
The objectives of this study are to assess and compare at 6 months 1) the percentage of subjects achieving bilateral uncorrected distance visual acuity and bilateral uncorrected near visual acuity <= 0.1 logMar; 2) spectacle independence at…
To assess uptake of 11C-osimertinib in tumor lesions of T790M double positive patients and T790M double negative patients, thereby evaluating specific and aspecific (off-target) 11C-osimertinib accumulation in tumor tissue.